Baylor College of Medicine Researchers Discover Metformin Acts on Brain

Baylor College of Medicine Researchers Discover Metformin Acts Directly on the Brain

However, a study published in Science Advances reveals a more complex mechanism involving a specific brain pathway. According to lead researcher and neurobiologist Makoto Fukuda, We focus on the brain, as it is widely recognized as a key regulator of metabolism, as noted by Excelsior.

The Role of the Rap1 Protein and SF1 Neurons

To investigate the brain’s role, the research team focused on a protein named Rap1 located in the ventromedial nucleus of the hypothalamus (VMH), a brain region known to regulate metabolism and whole-body glucose balance. Using genetically modified mouse models lacking the Rap1 protein in this specific area, scientists observed that the animals stopped responding to metformin when fed a high-fat diet.

Without Rap1 in the ventromedial hypothalamus, metformin failed to lower blood sugar levels in the mice. Interestingly, other diabetes treatments such as insulin and GLP-1 agonists continued to work in these modified animals, indicating that Rap1 plays a specific, exclusive role in how metformin triggers its cerebral pathway. Furthermore, the drug activated a specific group of SF1 neurons in the ventromedial hypothalamus, which are responsible for regulating appetite, sugar, and energy balance.

Microdosing Experiments Reveal High Brain Sensitivity

To test whether the brain mediates the drug’s effects, researchers administered microdoses of metformin—just 1 microgram, or thousands of times lower than standard oral or peripheral doses—directly into the brains of obese mice with diabetes. Even at these drastically reduced quantities, the targeted treatment significantly lowered blood glucose levels.

Researchers noted that the dramatic effect observed with such minute quantities suggests that the brain possesses a high sensitivity to metformin, responding to much lower concentrations than peripheral organs like the liver or gut.

Broader Implications and Current Limits of the Discovery

While the findings provide a deeper understanding of metformin, which was synthesized in 1922 and ranked as the second most prescribed medication in the United States during 2023 according to almomento.mx, experts emphasize that it does not immediately change clinical medical treatment or patient dosages. Because the work was performed primarily in animal models, additional research is required to determine whether the Rap1 signaling pathway functions similarly in humans and how it can be safely utilized.

Looking ahead, the research team plans to explore whether the Rap1 brain signaling pathway is responsible for other documented properties of the drug. Specifically, investigators want to study potential links between the mechanism and previously noted associations between metformin, delayed brain aging, and the extension of human longevity.